The role of structurally conserved class I MHC in tumor rejection: Contribution of the Q8 locus

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2123-2130

  Chiang, Eugene Y ^a   Stroynowski, Iwona ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN Q8; PROTEIN Q9; PROTEIN QA 2; UNCLASSIFIED DRUG;

19 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; GENE; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; HAPLOTYPE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; Q8 GENE; QA 2 GENE; SEQUENCE ANALYSIS; TUMOR; TUMOR MODEL; TUMOR REJECTION;

EID: 33746876730     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2123     Document Type: Article

References (48)

1. Chiang, E. Y., M. Henson, and I. Stroynowski. 2003. Correction of defects responsible for impaired Qa-2 class Ib MHC expression on melanoma cells protects mice from tumor growth. J. Immunol. 170: 4515-4523.
2. Chiang, E. Y., and I. Stroynowski. 2004. A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor. J. Immunol. 173: 4394-4401.
3. Chiang, E. Y., and I. Stroynowski. 2005. Protective immunity against disparate tumors is mediated by a nonpolymorphic MHC class I molecule. J. Immunol. 174: 5367-5374.
4. Ungchusri, T., E. Y. Chiang, G. Brown, M. Chen, P. Tabaczewski, L. Timares, and I. Stroynowski. 2001. Widespread expression of the nonclassical class I Qa-2 antigens in hemopoietic and nonhemopoietic cells. Immunogenetics 53: 455-467.
5. Griffiths, E., H. Ong, M. J. Soloski, M. F. Bachmann, P. S. Ohashi, and D. E. Speiser. 1998. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I. Cancer Rex. 58: 4682-4687.
6. Weiss, E. H., L. Golden, K. Fahrner, A. L. Mellor, J. J. Devlin, H. Bullman, H. Tiddens, H. Bud, and R. A. Flavell. 1984. Organization and evolution of the class I gene family in the major histocompatibility complex of the C57BL/10 mouse. Nature 310: 650-655.
7. Devlin, J. J., E. H. Weiss, M. Paulson, and R. Flavell. 1985. Duplicated gene pairs and alleles of class I genes in the Qa-2 region of the murine major histocompatibility complex: a comparison. EMBO J. 4: 3203-3207.
8. Kumánovics, A., A. Madan, S. Qin, L. Rowen, L. Hood, and K. Fischer Lindahl. 2002. Quod erat faciendum: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. Immunogenetics 54: 479-489.
9. Lowen, L. C., C. J. Aldrich, and J. Forman. 1993. Analysis of T cell receptors specific for recognition of class Ib antigens. J. Immunol. 151: 6155-6165.
10. Chiang, E. Y., M. Henson, and I. Stroynowski. 2002. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from natural killer cell- and lymphokine-activated killer cell-mediated cytolysis. J. Immunol. 168: 2200-2211.
11. Hasenkrug, K. J., J. M. Cory, and J. H. Stimpfling. 1987. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogenetics 25: 136-139.
12. b haplotype reveal genetic control of isotype expression. J. Immunol. 126: 317-321.
13. d antigens on the surface of these cells. Transplantation 34: 113-120.
14. Tabaczewski, P., E. Chiang, M. Henson, and I. Stroynowski. 1997. Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides. J. Immunol. 159: 2771-2781.
15. Joyce, S., P. Tabaczewski, R. H. Angeletti, S. G. Nathenson, and I. Stroynowski. 1994. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides. J. Exp. Med. 179: 579-588.
16. Rötzschke, O., K. Falk, S. Stevanović, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21: 2891-2894.
17. Waneck, G. L., M. E. Stein, and R. A. Flavell. 1988. Conversion of a PI-anchored protein to an integral membrane protein by a single amino acid mutation. Science 241: 697-699.
18. Ulker, N., L. E. Hood, and I. Stroynowski. 1990. Molecular signals for phosphatidylinositol modification of the Qa-2 antigen. J. Immunol. 145: 2214-2219.
19. Cai, W., W. Cao, L. Wu, G. E. Exley, G. L. Waneck, B. L. Karger, and C. M. Warner. 1996. Sequence and transcription of Qa-2-encoding genes in mouse lymphocytes and blastocysts. Immunogenetics 45: 97-107.
20. Mann, D., and J. Forman. 1988. Recognition by cytotoxic T lymphocytes of Qa-2 antigens: sensitivity of Qa-2 molecules to phosphatidylinositol-specific phospholipase C. J. Immunol. 141: 1813-1818.
21. Stiernberg, J., M. G. Low, L. Flaherty, and P. W. Kincade. 1987. Removal of lymphocyte surface molecules with phosphatidylinositol-specific phospholipase C: effects on mitogen responses and evidence that ThB and certain Qa antigens are membrane-anchored via phosphatidylinositol. J. Immunol. 138: 3877-3884.
22. Straus, D. S., I. Stroynowski, S. G. Schiffer, and L. Hood. 1985. Expression of hybrid class I genes of the major histocompatibility complex in mouse L cells. Proc. Natl. Acad. Sci. USA 82: 6245-6249.
23. Sharrow, S. O., J. S. Arn, I. Stroynowski, L. Hood, and D. H. Sachs. 1989. Epitope clusters of Qa-2 antigens defined by a panel of new monoclonal antibodies. J. Immunol. 142: 3495-3502.
24. Wu, T. C., A. Y. Hwang, E. M. Jaffee, H. I. Levitsky, and D. M. Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182: 1415-1421.
25. Rotzschke, O., K. Falk, S. Stevanović, B. Grahovac, M. J. Soloski, G. Jung, and H. G. Rammensee. 1993. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Nature 361: 642-644.
26. He, X.-L., P. Tabaczewski, J. Ho, I. Stroynowski, and K. C. Garcia. 2001. Promiscuous antigen presentation by the nonelassieal MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation. Structure 9: 1213-1224.
27. Levitsky, H. I., A. Lazenby, R. J. Hayashi, and D. M. Pardoll. 1994. In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J. Exp. Med. 179: 1215-1224.
28. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
29. Pullen, J. K., R. M. Horton, Z. L. Cai, and L. R. Pease. 1992. Structural diversity of the classical H-2 genes: K, D, and L. J. Immunol. 148: 953-967.
30. Kumánovics, A., T. Takada, and K. F. Lindahl. 2003. Genomic organization of the mammalian MHC. Annu. Rev. Immunol. 21: 629-657.
31. Michaelson, J., L. Flaherty, B. Hutchinson, and H. Yudkowitz. 1982. Qa-2 does not display structural genetic polymorphism detectable on isoelectric-focusing gels. Immunogenetics 16: 363-366.
32. Tine, J. A., A. Walsh, D. Rathbun, L. Leonard, E. K. Wakeland, R. Dilwith, and L. Flaherty. 1990. Genetic polymorphisms of Q region genes from wild-derived mice: implications for Q region evolution. Immunogenetics 31: 315-325.
33. d gene by T cells of the mouse. Immunogenetics 30: 156-161.
34. d of the BALB/cJ mouse strain cannot encode a Qa-2.3 class I antigen. Immunogenetics 33: 225-234.
35. b in a transfected cell line. Immunogenetics 34: 179-184.
36. Tabaczewski, P., H. Shirwan, K. Lewis, and I. Stroynowski. 1994. Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood. Proc. Natl. Acad. Sci. USA 91: 1883-1887.
37. Stroynowski, I., M. Soloski, M. G. Low, and L. Hood. 1987. A single gene encodes soluble and membrane-bound forms of the major histocompatibility Qa-2 antigen: anchoring of the product by a phospholipid tail. Cell 50: 759-768.
38. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518.
39. Rudolph, M. G., J. G. Luz, and I. A. Wilson. 2002. Structural and thermodynamic correlates of T cell signaling. Annu. Rev. Biophys. Biomol. Struct. 31: 121-149.
40. Garcia, K. C., and E. J. Adams. 2005. How the T cell receptor sees antigen: a structural view. Cell 122: 333-334.
41. Whitelegg, A., and L. D. Barber. 2004. The structural basis of T-cell allorecognition. Tissue Antigens 63: 101-108.
42. Blattman, J. N., R. Antia, D. J. Sourdive, X. Wang, S. M. Kaech, K. Murali-Krishna, J. D. Altman, and R. Ahmed. 2002. Estimating the precursor frequency of naïve antigen-specific CD8 T cells. J. Exp. Med. 195: 657-664.
43. Huseby, E. S., J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, P. Marrack, and J. W. Kappler. 2005. How the T cell receptoire becomes peptide and MHC specific. Cell 122: 247-260.
44. Reed-Loisel, L. M., B. A. Sullivan, O. Laur, and P. E. Jensen. 2005. An MHC class 1b-restricted TCR that cross-reacts with an MHC class 1a molecule. J. Immunol. 174: 7746-7752.
45. Ploss, A., G. Lauvau, B. Conlos, K. M. Kerksiek, P. D. Guirnalda, I. Leiner, L. L. Lenz, M. J. Bevan, and E. G. Pamer. 2003. Promiscuity of MHC class 1b-restricted T cell responses. J. Immunol. 171: 5948-5955.
46. Lo, W. F., A. S. Woods, A. DeCloux, R. J. Cotter, E. S. Metcalf, and M. J. Soloski. 2000. Molecular mimicry mediated by MHC class 1b molecules after infection with Gram-negative pathogens. Nat. Med. 6: 215-218.
47. Shamshiev, A., A. Donda, T. I. Prigozy, L. Mori, V. Chigorno, C. A. Benedict, L. Kappos, S. Sonnino, M. Kronenberg, and G. De Libero. 2000. The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13: 255-264.
48. Prendergast, M. M., A. J. Lastovica, and A. P. Moran. 1998. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barre syndrome exhibit mimicry of GM1 ganglioside. Infect. Immun. 66: 3649-3655.